Relay Therapeutics (RLAY) President of R&D Donald Bergstrom Sells Shares

What Happened Donald A. Bergstrom, President, R&D at Relay Therapeutics (RLAY), sold 2,237 shares on July 28, 2026, at $18.61 per share for a total of $41,631. The sale was a disposition (S) and was executed to satisfy income tax withholding related to the vesting of RSUs, not a discretionary investment sale.

Key Details

• Transaction date and price: July 28, 2026 — 2,237 shares at $18.61 ($41,631 total).
• Reason/footnote: Sale done to cover tax withholding on 5,012 RSUs that vested July 27, 2026; the reporting person had no discretion over the sale and it followed issuer policy (Footnote F1).
• Holdings note: Filing indicates holdings include 10,025 shares underlying RSUs (Footnote F2). The Form 4 did not state a separate total common-stock ownership beyond that footnote.
• Timeliness: Report filed July 30, 2026 (period of report July 28, 2026); this appears timely under Form 4 reporting rules.

Context

• This was a routine tax-withholding sale tied to RSU vesting rather than an independent decision to sell shares. Such sales are common after equity awards vest and generally do not signal a change in insider conviction.